Over the Counter

In a bonus episode of the Over the Counter podcast, William A. Bryson, PharmD, joined to help celebrate Diabetes Alert Day—recognized annually on the fourth Tuesday in March.

With ongoing concerns about the safety and formulation of compounded GLP-1s, Annie Lambert, PharmD, BCSCP, added her expert insights into the recent crackdown of these products.

With drug shortages continuing to disrupt patient care and pharmacy operations, Lani Bertrand breaks down how AI and automation are reshaping the way pharmacies respond to supply chain disruptions.

With a key exemption under DSCSA expiring at the end of the year, Matt Sample from Cencora helps pharmacies understand the tools and processes they need now to best comply with the law.

With patients and pharmacists existing in new territories since the COVID-19 pandemic, at-home diagnostic testing has come a long way in improving the potential for convenient access to care.

With the federal government continuing its reconsideration of vaccine guidelines in the US, Jeff Goad, PharmD, MPH, explains what it means for community pharmacies.

As the pharmacy industry seemingly transforms in real-time, expert pharmacists and digital health experts explain how DTP models are paving a new path for drug distribution.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In a recap of his recent NPhA continuing pharmacy education presentation, Kenric B. Ware, PharmD, MBA, AAHIVP, discussed pharmacists’ role in addressing HIV stigma.

During his second term, President Trump has bolstered his approach at lowering prescription drug prices in the US through innovative yet unprecedented decisions.

With constant vaccine and guideline updates reserved for pneumococcal diseases, pharmacists continue to be the authority on pneumococcal vaccine administration.

Leading health care economist and public policy expert John C. Goodman, PhD, breaks down what various supply chain entities can expect with TrumpRx.

Jeffrey Bratberg, PharmD, BCPS, and Michelle Caetano, PharmD, BCACP, CVDOE, CDOE, BCPT, discuss the Pharmacy Bridge resource and pharmacists’ role in OUD management.

Patient safety organizations began in the early 21st century to improve health care safety measures amongst various providers’ practices.

A conversation with NCPDP’s Rick Sage explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.

With a new year approaching, pharmacy law experts joined Over the Counter to recap some of the key events regarding state- and federal-level PBM reform throughout 2025.

Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.

From the COVID-19 pandemic through state-by-state expansion of scope, pharmacists have tapped into a variety of their clinical skills to bolster patient outcomes in their communities.

With the constant financial hurdles businesses face, the community pharmacy industry has struggled with finding new ways to innovate within its practices.

Exploring the evolution of pharmacy education throughout his professional career, Brad Phillips, PharmD, BCACP, joined Over the Counter to discuss trends in pharmacy students’ career paths.

In today’s world, the exponential use of technology is gradually becoming commonplace, and pharmacy businesses are expected to keep up with the growing digital landscape.

As contraceptive care services remain fragmented across many US states, pharmacists are seemingly rising as key touch points for women’s health management and various types of reproductive care.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

As GLP-1 popularity, use, and price continues to rise, pharmacy industry stakeholders are attempting to guide pharmacists and patients around the complexities of this drug class.